Anti-HPV45 Major capsid protei
n L1 Antibody (6G6), 抗HPV45Major capsid protein L1抗体 (6G6)- 询价
- abinScience
- China
- VK122013
- 2026年03月03日
- ELISA-cap, Neutralization
- Mouse
- Human papillomavirus 45 (HPV45)
企业认证
相关产品推荐更多 >
Anti-Human S100A9 Antibody (SAA1819), 抗人S100A9抗体 (SAA1819)
￥1176
Human IgG4 (S228P/L235E/R409K), kappa Isotype Control Antibody (HyHEL-10), 同型对照抗体
询价Anti-Human CD2 Antibody (G11), PE, 抗人CD2抗体 (G11), PE标记
询价
Anti-Omalizumab Non-Neutralizing Antibody (SAA2622), 抗OmalizumabNon-Neutralizing抗体 (SAA2622)
询价
Anti-Human ERP44 Polyclonal Antibody, 抗人ERP44 Polyclonal抗体
￥1008
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
\
- 亚型：
IgG2b
- 形态：
Liquid
- 保存条件：
0.01M PBS pH 7.4
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human papillomavirus 45 (HPV45)
- 保质期：
1 year
- 抗原来源：
Mouse
- 目录编号：
VK122013
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Mouse
- 应用范围：
ELISA-cap, Neutralization
- 浓度：
1mg/ml
- 靶点：
L1, Major capsid protein L1
- 抗体英文名：
Anti-HPV45 Major capsid protein L1 Antibody (6G6)
- 抗体名：
Anti-HPV45 Major capsid protein L1 Antibody (6G6)
- 规格：
50ug/100ug/1mg
| Product name | Anti-HPV45 Major capsid protein L1 Antibody (6G6) |
|---|---|
| Catalog No. | VK122013 |
| Host species | Mouse |
| Species reactivity | Human papillomavirus 45 (HPV45) |
| Immunogen | \ |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Clonality | Monoclonal |
| Isotype | IgG2b |
| Applications | ELISA-cap, Neutralization |
| Target | L1, Major capsid protein L1 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Accession | P36741 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Clone ID | 6G6 |
| Note | For research use only |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for ab...
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验• Intragenic L1 Insertion: One Possibility of Brain Disorder. PMID: 36143463
• Exosomal PD-L1 in cancer and other fields: recent advances and perspectives. PMID: 38726017
• L1-CAM in cancerous tissues. PMID: 18847309
• PD-L1 expression as a predictive biomarker for immune checkpoint inhibitors: between a dream and a nightmare. PMID: 34190579
• Emerging role of PD-L1 modification in cancer immunotherapy. PMID: 34522452
• Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies. PMID: 33178688
• PD-L1 expression in sarcomas: An immunohistochemical study and review of the literature. PMID: 34656856
• L1-CAM as a target for treatment of cancer with monoclonal antibodies. PMID: 20044598
• The Prognostic and Therapeutic Value of PD-L1 in Glioma. PMID: 30687086
不止是粒细胞标志物！CEACAM8在脓毒症诊断与肿瘤免疫中的最-新研究进展
66b的表达在扩散组中显著高于非扩散组，并且侵袭性亚组的生存率更低。CD66b阳性TANs与淋巴结转移、远处转移密切相关。进一步的研究结果显示CD66b+TANs会影响免疫细胞上PD-L1的表达，二者呈正相关的关系。总之，乳腺癌中存在TANs，且与肿瘤的转移、复发密切相关，检测CD66b阳性TANs的密度可能成为预测乳腺癌转移和复发的潜在指标 [16-17]。 3.2 CEACAM8和宫颈癌研究 宫预癌组织中，中粒细胞的浸润与患者无复发生存（RFS）密切
和表达基因 逆转录病毒只能感染增殖性细胞，因此DNA转染不能在非增殖细胞中进行，而必须使细胞处于持续培养状态。腺病毒则能感染几乎所有的细胞类型，除了一些抗腺病毒感染的淋巴瘤细胞。腺病毒是研究原代非增殖细胞基因表达的最佳系统，它可以使转化细胞和原代细胞中得到的结果直接进行对比。 3. 能有效进行增殖，滴度高 腺病毒系统可产生1010到1011VP/ml，浓缩后可达1013VP/ml，这一特点使它非常适用于基因治疗。 4. 与人类基因同源 腺病毒载体系统一般应用人类病毒作为载体
中科院高福院士课题组 2019 年发表了哪些重要的研究成果？
小分子化学物质，可能是潜在的 ASFV 候选药物。图片来源：Mbio研究结果为靶向 E165R 的抗 ASFV 药物设计提供了重要依据。原文链接：https://doi.org/10.1128 /mBio.02483 - 19Cell Reports：Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope（靶向黄热病病毒包膜的人中
技术资料暂无技术资料 索取技术资料
